What do we know about biosimilar biologics?

Reports on biosimilar medicines


Although it is true that up to now most of these drugs in Spain are for use and dispensing at the hospital level, some of them have already reached community pharmacies (certain insulins, for example) and there are surely many more who do so. do over the next few years, thus achieving greater accessibility by patients.

BioSim Newsletter

Subscribe to receive a weekly summary of current events on biosimilar medicines in your email.

SUBSCRIBE